真皮填充剂：全球前景和预测 (2023-2028)

从 2022 年到 2028 年，全球真皮填充剂市场规模预计将以 8.03% 的复合年增长率增长。

男性对美容的需求不断增加、医疗旅游导致获得美容医学的机会增加、对非侵入性整容手术的需求增加以及对整容手术的认识和支出不断增加等因素正在推动市场的增长。 .

本报告调查了全球真皮填充剂市场，提供了市场定义和概述、市场机会和市场趋势、市场影响因素分析、市场规模趋势和预测，以及每个细分市场和地区的详细分析、竞争格局、概况大公司等

内容

第一章研究方法论

第二章研究目的

第三章研究过程

第四章调查对象和范围

第 5 章报告假设和註释

第 6 章市场概述

第 7 章重要注意事项

第8章介绍

第9章市场机会和市场趋势

• 对男性美容治疗的需求不断增长
• 整容手术和产品发布方面的进展
• 更容易获得整容手术和医疗旅游的兴起

第 10 章市场增长促成因素

• 对无创整容手术的需求激增
• 人口老龄化和对改善外表的兴趣日益浓厚
• 对美容和整容手术的认知度高，支出高

第11章市场约束

• 与真皮填充剂相关的并发症
• 真皮填充剂成本高
• 缺乏对真皮填充剂使用的监管

第 12 章市场状况

• 市场概览
• 市场规模和预测
  • 按地区划分的见解
  • 材料见解
  • 使用洞察
  • 性别见解
  • 最终用户的见解
• 五力分析

第13章材料

• 市场快照/增长引擎
• 市场概览
• 透明质酸
• 非透明质酸

第14章使用

• 市场快照/增长引擎
• 市场概览
• 强调嘴唇和脸颊
• 治疗皱纹和疤痕
• 音量恢復

第15章性别

• 市场快照/增长引擎
• 市场概览
• 女
• 男

第 16 章最终用户

• 市场快照/增长引擎
• 市场概览
• 医院
• 专业和皮肤科诊所
• 医疗水疗和美容中心

第十七章区域

• 市场快照/增长引擎
• 地理概览

第18章北美

第 19 章欧洲

第 20 章亚太地区

第21章拉丁美洲

第22章中东和非洲

第23章竞争格局

• 比赛总结
• 市场份额分析

第 24 章主要公司简介

• ABBVIE
• GALDERMA
• MERZ PHARMA
• SINCLAIR
• TEOXANE

第25章 其他供应商

• BIOPLUS
• BIOTECH
• CYTOPHIL
• DR. KORMAN
• FILLMED
• HUGEL
• MEDYTOX
• PROLLENIUM MEDICAL TECHNOLOGIES
• SHANGHAI BIOHA TECHNOLOGY
• SUNEVA MEDICAL

第26章报告总结

• 要点
• 战略建议

第 27 章定量总结

第 28 章附录

The global dermal fillers market is expected to grow at a CAGR of 8.03% during 2022 to 2028

MARKET TRENDS & DRIVERS

Advancements in Aesthetics & Product Launches

Over the last decade, the dermal fillers market has witnessed the launch of advanced products and innovative non-invasive procedures. Rapid and varied changes in dermatology care and advances in technology in aesthetics paved the direction for innumerable procedures that reduced the side effects. There is a significant trend among dermal filler manufacturers to focus on launching new and innovative products into the industry. Many want to provide clients with various filler options to suit their needs.

Increasing Demand for Male Aesthetics

The desire to improve one's appearance is not limited strictly to women. Men increasingly seek treatments to address aesthetic concerns, such as wrinkle reduction, fat or cellulite removal, facial rejuvenation, and hair restoration. This shift in attitude towards male aesthetics can also be attributed to the evolving expectations of modern men. The trend is leaning towards a more youthful, toned, and vibrant aesthetic for men, and it's becoming increasingly common to see men seeking treatments to improve their appearance, further contributing to the dermal fillers market.

Better Access to Cosmetic Procedures Coupled with Medical Tourism

Cosmetic procedures are now a major component of medical tourism. Cosmetic procedures are performed for aesthetic or cosmetic purposes rather than medical necessity. Medical tourists may find the cost of dermal fillers much lower in other countries and may also be able to access treatments unavailable in their home country. By taking advantage of medical tourism, patients can access treatments they may not be able to get in their home country.

Increasing Demand for Non-invasive Aesthetic Procedures

As technology and treatments have evolved to deliver without pain and in less recovery time, such as non-invasive treatment, more people are opting for those procedures in recent years and more than ever. Dermal fillers are a non-invasive aesthetic procedure because they do not require surgery and can be administered with minimal risks and side effects. Dermal fillers involve injecting substances below the skin's surface to fill in wrinkles and create volume in areas of the face.

Aging Demographics & Increasing Focus on Improving Appearance

The rapidly growing elderly population and considerable focus on personal grooming and aesthetic appearance primarily drive the demand for dermal fillers. Consumers are more aware of how the sun, environment, and lifestyle factors can age their skin. Dermal fillers can provide immediate, natural-looking results lasting several months to two years or more. They can help eliminate wrinkles and lines, reduce scarring, restore fullness, enhance facial contours, and add volume and shape to hollow or thinning areas, such as sunken cheeks and recessed temples.

Increasing Awareness & Expenditure on Aesthetic/Cosmetic Procedures

Increasing awareness about aesthetic procedures through various platforms and rising per capita expenditure on cosmetics have significantly contributed to the dermal fillers market growth. The rising healthcare expenditure with changing human habits and lifestyles, rising income, and care about appearance have the expenditure on personal care. The demand for dermal fillers will keep rising as the population ages and people become more interested in aesthetics. Aesthetic procedures are becoming increasingly popular due to technological advances and a growing range of procedures available. Patients can now choose from a variety of treatments, including dermal fillers, as well as surgical and non-surgical procedures.

SEGMENTATION INSIGHTS

INSIGHTS BY MATERIAL

The global dermal fillers market by the material is segmented into hyaluronic acid (HA) and non-hyaluronic acid dermal fillers (calcium hydroxylapatite fillers, poly-l-lactic acid fillers, polymethylmethacrylate beads, and other). Hyaluronic Acid Fillers are biodegradable and the most commonly used dermal fillers because of their clear history of safety, freshness, and affordability. Additionally, due to their versatility and adaptability, hyaluronic acid fillers can create natural-looking results and address a variety of indications. In 2022, Hyaluronic acid (HA) dominated the global dermal fillers market, and the trend is likely to continue during the forecast period.

Segmentation by Material

• Hyaluronic Acid
• Non-hyaluronic Acid

INSIGHTS BY APPLICATION

The lips & cheeks enhancement application segment had the highest global dermal fillers market share in 2022. Dermal filler can be used in lips enhancement, adding volume, shape, and definition to the lips. They can also minimize wrinkles and vertical lines above and around the lips. The most commonly used dermal filler for lips enhancement is hyaluronic acid-based fillers. They can be used to enhance the shape, size, and symmetry of the lips and reduce wrinkles in the lip area. Examples of commonly used dermal fillers include Juvederm, Radiesse, Belotero, and Restylane. These fillers are developed with hyaluronic acid, a naturally occurring substance in the skin, which can enhance lips and cheeks. The fillers also contain lidocaine, a numbing agent, to reduce discomfort during injections.

Segmentation by Application

• Lips & Cheeks Enhancement
• Wrinkle & Scar Treatment
• Restoration of Volume

INSIGHTS BY GENDER

Dermal fillers are becoming increasingly popular among men and women as a non-invasive treatment for facial aging. The female segment dominated the global dermal fillers market in 2022. For women, dermal fillers often address age-related changes in facial structure, such as a flattening of the midface and loss of volume in the lips and cheeks. They can also fill in wrinkles and expression lines and subtly volumize and enhance specific features, such as a prominent nose or chin.

Segmentation by Gender

• Female
• Male

INSIGHTS BY END-USER

The global dermal fillers market by end-users is segmented into hospitals, specialty & dermatology clinics, and medical spas & beauty centers. Hospitals are the prime and major market growth contributors. The rising number of hospitals and demand for aesthetic procedures positively triggered the high market growth. In 2022, the hospital's segment accounted for 38.91% of the global dermal fillers market share. A plastic surgeon or dermatologist typically does the procedure in a hospital setting. The procedure typically takes less than 30 minutes, and results can often be seen immediately. The availability of the best practitioners, professionals, and experienced expertise, better access to aesthetic treatments, and the presence of high technology and advanced healthcare services derived high market growth by the segment.

Segmentation by End-user

• Hospitals
• Specialty & Dermatology Clinics
• Medical Spa & Beauty Centers

GEOGRAPHY ANALYSIS

North America is the most dominant region in the global dermal fillers market, and in 2022, the region accounted for over 33% of the global market size. The growing awareness about aesthetic procedures, advanced technology usage, increasing disposable income, and availability of recovery centers contribute to the region's market growth. Further, every year, Americans spend billions of dollars on cosmetic procedures indicating high per capita expenditure and wide acceptance of medical aesthetic procedures in the region.

Segmentation by Geography

• North America
  • US
  • Canada
• Europe
  • Germany
  • Italy
  • Spain
  • UK
  • France
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Australia
• Latin America
  • Brazil
  • Argentina
  • Mexico
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • South Africa

VENDOR LANDSCAPE

The global dermal fillers market is competitive and fast-growing, with many leading companies offering unique products. Manufacturers constantly race to gain market share and deliver innovative products that meet consumer expectations for quality, convenience, and results. Companies compete for customers by investing heavily in research and development to develop advanced dermal fillers. In addition to product innovation, companies are racing to provide the most competitive prices and best customer service. Manufacturers also aggressively advertise and promote their products to gain an edge in the marketplace.

Key Company Profiles

• AbbVie
• Galderma
• Merz Pharma
• Sinclair
• TEOXANE

Other Prominent Vendors

• BioPlus
• Biotech
• Cytophil
• Dr. Korman
• FILLMED
• HUGEL
• Medytox
• Prollenium Medical Technologies
• Shanghai Bioha Technology
• Suneva Medical

KEY QUESTIONS ANSWERED:

• 1. How big is the global dermal fillers market?
• 2. What is the growth rate of the dermal fillers market?
• 3. What are the growing trends in the dermal fillers market?
• 4. Who are the key players in the global dermal fillers market?
• 5. Which region holds the most significant global dermal fillers market share?

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

• 4.1 MARKET DEFINITION
  • 4.1.1 INCLUSIONS
  • 4.1.2 EXCLUSIONS
  • 4.1.3 MARKET ESTIMATION CAVEATS
• 4.2 BASE YEAR
• 4.3 SCOPE OF THE STUDY
  • 4.3.1 MARKET SEGMENTATION BY MATERIAL
  • 4.3.2 MARKET SEGMENTATION BY APPLICATION
  • 4.3.3 MARKET SEGMENTATION BY GENDER
  • 4.3.4 MARKET SEGMENTATION BY END-USER
  • 4.3.5 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

• 5.1 KEY CAVEATS
• 5.2 CURRENCY CONVERSION
• 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 PREMIUM INSIGHTS

• 7.1 OVERVIEW

8 INTRODUCTION

• 8.1 OVERVIEW
  • 8.1.1 INFLUENCE OF SOCIAL MEDIA

9 MARKET OPPORTUNITIES & TRENDS

• 9.1 RISE IN DEMAND FOR MALE AESTHETIC TREATMENTS
• 9.2 ADVANCES IN AESTHETIC TREATMENTS & PRODUCT LAUNCHES
• 9.3 BETTER ACCESS TO COSMETIC PROCEDURES & RISE IN MEDICAL TOURISM

10 MARKET GROWTH ENABLERS

• 10.1 SURGE IN DEMAND FOR NON-INVASIVE AESTHETIC PROCEDURES
• 10.2 AGING DEMOGRAPHICS & INCREASING FOCUS ON IMPROVING APPEARANCE
• 10.3 HIGH AWARENESS & EXPENDITURE ON AESTHETIC/COSMETIC PROCEDURES

11 MARKET RESTRAINTS

• 11.1 COMPLICATIONS ASSOCIATED WITH DERMAL FILLERS
• 11.2 HIGH COST OF DERMAL FILLERS
• 11.3 LACK OF REGULATIONS ASSOCIATED WITH USE OF DERMAL FILLERS

12 MARKET LANDSCAPE

• 12.1 MARKET OVERVIEW
• 12.2 MARKET SIZE & FORECAST
  • 12.2.1 GEOGRAPHY INSIGHTS
  • 12.2.2 MATERIAL SEGMENTATION INSIGHTS
  • 12.2.3 APPLICATION SEGMENTATION INSIGHTS
  • 12.2.4 GENDER SEGMENTATION INSIGHTS
  • 12.2.5 END-USER SEGMENTATION INSIGHTS
• 12.3 FIVE FORCES ANALYSIS
  • 12.3.1 THREAT OF NEW ENTRANTS
  • 12.3.2 BARGAINING POWER OF SUPPLIERS
  • 12.3.3 BARGAINING POWER OF BUYERS
  • 12.3.4 THREAT OF SUBSTITUTES
  • 12.3.5 COMPETITIVE RIVALRY

13 MATERIAL

• 13.1 MARKET SNAPSHOT & GROWTH ENGINE
• 13.2 MARKET OVERVIEW
• 13.3 HYALURONIC ACID
  • 13.3.1 MARKET OVERVIEW
  • 13.3.2 MARKET SIZE & FORECAST
  • 13.3.3 HYALURONIC ACID SEGMENT BY GEOGRAPHY
• 13.4 NON-HYALURONIC ACID
  • 13.4.1 MARKET OVERVIEW
  • 13.4.2 MARKET SIZE & FORECAST
  • 13.4.3 NON-HYALURONIC ACID SEGMENT BY GEOGRAPHY

14 APPLICATION

• 14.1 MARKET SNAPSHOT & GROWTH ENGINE
• 14.2 MARKET OVERVIEW
• 14.3 LIPS & CHEEKS ENHANCEMENT
  • 14.3.1 MARKET OVERVIEW
  • 14.3.2 MARKET SIZE & FORECAST
  • 14.3.3 LIPS & CHEEKS ENHANCEMENT BY GEOGRAPHY
• 14.4 WRINKLE & SCAR TREATMENT
  • 14.4.1 MARKET OVERVIEW
  • 14.4.2 MARKET SIZE & FORECAST
  • 14.4.3 WRINKLE & SCAR TREATMENT BY GEOGRAPHY
• 14.5 RESTORATION OF VOLUME
  • 14.5.1 MARKET OVERVIEW
  • 14.5.2 MARKET SIZE & FORECAST
  • 14.5.3 RESTORATION OF VOLUME BY GEOGRAPHY

15 GENDER

• 15.1 MARKET SNAPSHOT & GROWTH ENGINE
• 15.2 MARKET OVERVIEW
• 15.3 FEMALE
  • 15.3.1 MARKET OVERVIEW
  • 15.3.2 MARKET SIZE & FORECAST
  • 15.3.3 FEMALE SEGMENT BY GEOGRAPHY
• 15.4 MALE
  • 15.4.1 MARKET OVERVIEW
  • 15.4.2 MARKET SIZE & FORECAST
  • 15.4.3 MALE SEGMENT BY GEOGRAPHY

16 END USER

• 16.1 MARKET SNAPSHOT & GROWTH ENGINE
• 16.2 MARKET OVERVIEW
• 16.3 HOSPITALS
  • 16.3.1 MARKET OVERVIEW
  • 16.3.2 MARKET SIZE & FORECAST
  • 16.3.3 HOSPITALS SEGMENT BY GEOGRAPHY
• 16.4 SPECIALTY & DERMATOLOGY CLINICS
  • 16.4.1 MARKET OVERVIEW
  • 16.4.2 MARKET SIZE & FORECAST
  • 16.4.3 SPECIALTY & DERMATOLOGY CLINICS BY GEOGRAPHY
• 16.5 MEDICAL SPAS & BEAUTY CENTERS
  • 16.5.1 MARKET OVERVIEW
  • 16.5.2 MARKET SIZE & FORECAST
  • 16.5.3 MEDICAL SPA & BEAUTY CENTERS GEOGRAPHY

17 GEOGRAPHY

• 17.1 MARKET SNAPSHOT & GROWTH ENGINE
• 17.2 GEOGRAPHIC OVERVIEW

18 NORTH AMERICA

• 18.1 MARKET OVERVIEW
• 18.2 MARKET SIZE & FORECAST
  • 18.2.1 NORTH AMERICA BY MATERIAL SEGMENTATION
  • 18.2.2 NORTH AMERICA BY APPLICATION SEGMENTATION
  • 18.2.3 NORTH AMERICA BY GENDER SEGMENTATION
  • 18.2.4 NORTH AMERICA BY END-USER SEGMENTATION
• 18.3 KEY COUNTRIES
  • 18.3.1 US: MARKET SIZE & FORECAST
  • 18.3.2 CANADA: MARKET SIZE & FORECAST

19 EUROPE

• 19.1 MARKET OVERVIEW
• 19.2 MARKET SIZE & FORECAST
  • 19.2.1 EUROPE BY MATERIAL SEGMENTATION
  • 19.2.2 EUROPE BY APPLICATION SEGMENTATION
  • 19.2.3 EUROPE BY GENDER SEGMENTATION
  • 19.2.4 EUROPE BY END-USER SEGMENTATION
• 19.3 KEY COUNTRIES
  • 19.3.1 GERMANY: MARKET SIZE & FORECAST
  • 19.3.2 ITALY: MARKET SIZE & FORECAST
  • 19.3.3 SPAIN: MARKET SIZE & FORECAST
  • 19.3.4 UK: MARKET SIZE & FORECAST
  • 19.3.5 FRANCE: MARKET SIZE & FORECAST

20 APAC

• 20.1 MARKET OVERVIEW
• 20.2 MARKET SIZE & FORECAST
  • 20.2.1 APAC BY MATERIAL SEGMENTATION
  • 20.2.2 APAC BY APPLICATION SEGMENTATION
  • 20.2.3 APAC BY GENDER SEGMENTATION
  • 20.2.4 APAC BY END-USER SEGMENTATION
• 20.3 KEY COUNTRIES
  • 20.3.1 CHINA: MARKET SIZE & FORECAST
  • 20.3.2 JAPAN: MARKET SIZE & FORECAST
  • 20.3.3 SOUTH KOREA: MARKET SIZE & FORECAST
  • 20.3.4 INDIA: MARKET SIZE & FORECAST
  • 20.3.5 AUSTRALIA: MARKET SIZE & FORECAST

21 LATIN AMERICA

• 21.1 MARKET OVERVIEW
• 21.2 MARKET SIZE & FORECAST
  • 21.2.1 LATIN AMERICA BY MATERIAL SEGMENTATION
  • 21.2.2 LATIN AMERICA BY APPLICATION SEGMENTATION
  • 21.2.3 LATIN AMERICA BY GENDER SEGMENTATION
  • 21.2.4 LATIN AMERICA BY END-USER SEGMENTATION
• 21.3 KEY COUNTRIES
  • 21.3.1 BRAZIL: MARKET SIZE & FORECAST
  • 21.3.2 ARGENTINA: MARKET SIZE & FORECAST
  • 21.3.3 MEXICO: MARKET SIZE & FORECAST

22 MIDDLE EAST & AFRICA

• 22.1 MARKET OVERVIEW
• 22.2 MARKET SIZE & FORECAST
  • 22.2.1 MIDDLE EAST & AFRICA BY MATERIAL SEGMENTATION
  • 22.2.2 MIDDLE EAST & AFRICA BY APPLICATION SEGMENTATION
  • 22.2.3 MIDDLE EAST & AFRICA BY GENDER SEGMENTATION
  • 22.2.4 MIDDLE EAST & AFRICA BY END-USER SEGMENTATION
• 22.3 KEY COUNTRIES
  • 22.3.1 TURKEY: MARKET SIZE & FORECAST
  • 22.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
  • 22.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST

23 COMPETITIVE LANDSCAPE

• 23.1 COMPETITION OVERVIEW
• 23.2 MARKET SHARE ANALYSIS
  • 23.2.1 ABBVIE
  • 23.2.2 GALDERMA
  • 23.2.3 MERZ PHARMA
  • 23.2.4 SINCLAIR
  • 23.2.5 TEOXANE

24 KEY COMPANY PROFILES

• 24.1 ABBVIE
  • 24.1.1 BUSINESS OVERVIEW
  • 24.1.2 PRODUCT OFFERINGS
  • 24.1.3 KEY STRATEGIES
  • 24.1.4 KEY STRENGTHS
  • 24.1.5 KEY OPPORTUNITIES
• 24.2 GALDERMA
  • 24.2.1 BUSINESS OVERVIEW
  • 24.2.2 PRODUCT OFFERINGS
  • 24.2.3 KEY STRATEGIES
  • 24.2.4 KEY STRENGTHS
  • 24.2.5 KEY OPPORTUNITIES
• 24.3 MERZ PHARMA
  • 24.3.1 BUSINESS OVERVIEW
  • 24.3.2 PRODUCT OFFERINGS
  • 24.3.3 KEY STRATEGIES
  • 24.3.4 KEY STRENGTHS
  • 24.3.5 KEY OPPORTUNITIES
• 24.4 SINCLAIR
  • 24.4.1 BUSINESS OVERVIEW
  • 24.4.2 PRODUCT OFFERINGS
  • 24.4.3 KEY STRATEGIES
  • 24.4.4 KEY STRENGTHS
  • 24.4.5 KEY OPPORTUNITIES
• 24.5 TEOXANE
  • 24.5.1 BUSINESS OVERVIEW
  • 24.5.2 PRODUCT OFFERINGS
  • 24.5.3 KEY STRATEGIES
  • 24.5.4 KEY STRENGTHS
  • 24.5.5 KEY OPPORTUNITIES

25 OTHER PROMINENT VENDORS

• 25.1 BIOPLUS
  • 25.1.1 BUSINESS OVERVIEW
  • 25.1.2 PRODUCT OFFERINGS
• 25.2 BIOTECH
  • 25.2.1 BUSINESS OVERVIEW
  • 25.2.2 PRODUCT OFFERINGS
• 25.3 CYTOPHIL
  • 25.3.1 BUSINESS OVERVIEW
  • 25.3.2 PRODUCT OFFERINGS
• 25.4 DR. KORMAN
  • 25.4.1 BUSINESS OVERVIEW
  • 25.4.2 PRODUCT OFFERINGS
• 25.5 FILLMED
  • 25.5.1 BUSINESS OVERVIEW
  • 25.5.2 PRODUCT OFFERINGS
• 25.6 HUGEL
  • 25.6.1 BUSINESS OVERVIEW
  • 25.6.2 PRODUCT OFFERINGS
• 25.7 MEDYTOX
  • 25.7.1 BUSINESS OVERVIEW
  • 25.7.2 PRODUCT OFFERINGS
• 25.8 PROLLENIUM MEDICAL TECHNOLOGIES
  • 25.8.1 BUSINESS OVERVIEW
  • 25.8.2 PRODUCT OFFERINGS
• 25.9 SHANGHAI BIOHA TECHNOLOGY
  • 25.9.1 BUSINESS OVERVIEW
  • 25.9.2 PRODUCT OFFERINGS
• 25.10 SUNEVA MEDICAL
  • 25.10.1 BUSINESS OVERVIEW
  • 25.10.2 PRODUCT OFFERINGS

26 REPORT SUMMARY

• 26.1 KEY TAKEAWAYS
• 26.2 STRATEGIC RECOMMENDATIONS

27 QUANTITATIVE SUMMARY

• 27.1 BY MATERIAL SEGMENTATION
  • 27.1.1 NORTH AMERICA BY MATERIAL
  • 27.1.2 EUROPE BY MATERIAL
  • 27.1.3 APAC BY MATERIAL
  • 27.1.4 LATIN AMERICA BY MATERIAL
  • 27.1.5 MIDDLE EAST & AFRICA BY MATERIAL
• 27.2 BY APPLICATION SEGMENTATION
  • 27.2.1 NORTH AMERICA BY APPLICATION
  • 27.2.2 EUROPE BY APPLICATION
  • 27.2.3 APAC BY APPLICATION
  • 27.2.4 LATIN AMERICA BY APPLICATION
  • 27.2.5 MIDDLE EAST & AFRICA BY APPLICATION
• 27.3 BY GENDER SEGMENTATION
  • 27.3.1 NORTH AMERICA BY GENDER
  • 27.3.2 EUROPE BY GENDER
  • 27.3.3 APAC BY GENDER
  • 27.3.4 LATIN AMERICA BY GENDER SEGMENT
  • 27.3.5 MIDDLE EAST & AFRICA BY GENDER
• 27.4 BY END-USER SEGMENTATION
  • 27.4.1 NORTH AMERICA BY END USER
  • 27.4.2 EUROPE BY END USER
  • 27.4.3 APAC BY END USER
  • 27.4.4 LATIN AMERICA BY END USER
  • 27.4.5 MIDDLE EAST & AFRICA BY END USER
• 27.5 MARKET BY GEOGRAPHY
  • 27.5.1 HYALURONIC ACID SEGMENT BY GEOGRAPHY
  • 27.5.2 NON-HYALURONIC ACID SEGMENT BY GEOGRAPHY
  • 27.5.3 LIPS & CHEEKS ENHANCEMENT BY GEOGRAPHY
  • 27.5.4 WRINKLE & SCAR TREATMENT BY GEOGRAPHY
  • 27.5.5 RESTORATION OF VOLUME BY GEOGRAPHY
  • 27.5.6 HOSPITALS SEGMENT BY GEOGRAPHY
  • 27.5.7 SPECIALTY & DERMATOLOGY CLINICS BY GEOGRAPHY
  • 27.5.8 MEDICAL SPAS & BEAUTY CENTERS GEOGRAPHY

28 APPENDIX

• 28.1 ABBREVIATIONS